What is Medivolve?
Founded in 2005 and headquartered in Toronto, Ontario, Medivolve operates as a healthcare technology and services company. Its focus lies in leveraging technological advancements to enhance healthcare delivery and services, positioning itself as a key player in a rapidly evolving industry. The company's trajectory suggests a commitment to innovation and expansion within the health-tech landscape.
How much funding has Medivolve raised?
Medivolve has raised a total of $16.9M across 3 funding rounds:
Share Placement
$12M
Share Placement
$887K
Share Placement
$4M
Share Placement (2021): $12M, investors not publicly disclosed
Share Placement (2022): $887K, investors not publicly disclosed
Share Placement (2023): $4M, investors not publicly disclosed
What's next for Medivolve?
The recent major strategic investment signals a pivotal growth phase for Medivolve. This influx of capital is likely to fuel further research and development, expansion of service offerings, and potentially strategic acquisitions. Medivolve is poised to capitalize on its technological capabilities to address critical needs within the healthcare ecosystem, aiming for sustained growth and market leadership.
See full Medivolve company page
